ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "physical function"

  • Abstract Number: 2186 • 2019 ACR/ARP Annual Meeting

    What Is an Important Difference in Gait Speed in Adults with Knee Osteoarthritis?

    Jing Song 1, David Cella 2, Abigail Gilbert3, Rowland Chang 2 and Dorothy Dunlop 2, 1Northwestern University Feinberg School of Medicine, Worthington, OH, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3University of North Carolina, Chapel Hill, NC

    Background/Purpose: Little is known regarding what difference in functional performance measures are clinically significant in individuals with a chronic medical disease. This study examines the…
  • Abstract Number: 2259 • 2019 ACR/ARP Annual Meeting

    Physical Challenges in RA: A Qualitative Study of an Online Patient Support Group

    Jude des Bordes 1, Jessica Foreman 1, Maria Lopez-Olivo1, Susan K Peterson 1, Tiffany Westrich-Robertson 2, Catherine Hofstetter 3, Anne Lyddiatt 4, Amye Leong 5 and Maria E. Suárez-Almazor 6, 1The University of Texas, MD Anderson Cancer Center, Houston, TX, 2International Foundation for Autoimmune and Autoinflammatory Arthritis, Saint Louis, MO, 3Patient advocate, Toronto, ON, Canada, 4Musculoskeletal Group, Cochrane Collaboration, Toronto, ON, Canada, 57. Healthy Motivation and the Global Alliance for Musculoskeletal Health of the Bone and Joint Decade, Santa Barbara, CA, 6Department of Rheumatology/Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX , USA., Houston, TX

    Background/Purpose: Patients with rheumatoid arthritis (RA) face a number of challenges which adversely affect their quality of life. The objective was to qualitatively evaluate content…
  • Abstract Number: 2453 • 2019 ACR/ARP Annual Meeting

    Static and Longitudinal Construct Validity of PROMIS CAT and Profile29 for Assessing Pain Interference, Physical Function and Fatigue in Psoriatic Arthritis

    Ana-Maria Orbai1, Jamie Perin 2, Albert W Wu 3, Katherine C. Smith 4 and Clifton Bingham 5, 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins University School of Public Health, Department of International Health, Baltimore, 3Johns Hopkins University Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, MD, 4Johns Hopkins University Bloomberg School of Public Health, Department of Health, Behavior and Society, Baltimore, MD, 5Johns Hopkins University, Baltimore, MD

    Background/Purpose: Pain, physical function and fatigue are outcomes reported as having the greatest importance to people with psoriatic arthritis (PsA)1,2. We assessed these outcomes in…
  • Abstract Number: 561 • 2019 ACR/ARP Annual Meeting

    Analysing Impairments in Physical Performance as Assessed by the as Performance Index (ASPI) in Patients with Axial Spondyloarthritis (axSpA)

    Eerik Ahomaa 1, Uta Kiltz2, Björn Bühring 3, Xenofon Baraliakos 4, Salima van weely 5 and Jürgen Braun 6, 1Rheumazentrum Ruhrgebiet and Ruhr-University Bochum, Bochum, Germany, 2Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, 3Rheumazentrum Ruhrgebiet and Ruhr-University Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet-Ruhr-University Bochum, Herne, Germany, Herne, Germany, 5Orthopedics, Rehabilitation and Physical Therapy dpt., Leiden University Medical Center, Leiden, Netherlands, 6Rheumazentrum Ruhrgebiet/Ruhr University, Herne, Germany

    Background/Purpose: In patients with axial spondyloarthritis (axSpA) physical functioning is frequently impaired. The current gold standard to assess physical functioning is self-reported questionnaires (i.e. BASFI),…
  • Abstract Number: 612 • 2019 ACR/ARP Annual Meeting

    Objective Ankylosing Spondylitis Physical Performance Index (ASPI) Is Highly Reliable and Feasible in Chilean Patients

    Rianne van Bentum1, Sebastian Ibáñez Vodnizza 2, Francisca Valenzuela Aldridge 2, Maria Paz Poblete 3, Salima van weely 4, Marieke ter Wee 1, Omar Valenzuela 5 and Irene van der Horst-Bruinsma 1, 1Amsterdam Rheumatology and immunology Center, Rheumatology, Amsterdam University Medical Center location VUmc, Amsterdam, Amsterdam, Netherlands, 2Rheumatology dpt., Clínica Alemana - UDD Medicine faculty, Santiago, Chile, 3Rheumatology dpt., Facultad de Medicina Clinica Alemana - UDD, Santiago, Region Metropolitana, Chile, 4Orthopedics, Rehabilitation and Physical Therapy dpt., Leiden University Medical Center, Leiden, Netherlands, 5Facultad de Medicina Clinica Alemana -UDD, Santiago, Region Metropolitana, Chile

    Background/Purpose: In axial spondyloarthritis (axSpA), preservation of physical functioning is an important treatment goal and is usually assessed with the patient-reported BASFI questionnaire. The Ankylosing…
  • Abstract Number: 1170 • 2019 ACR/ARP Annual Meeting

    Cortical Bone Erosion in the 2nd Metacarpal Bone Head: Association with Its Bone Mineral Density by HR-pQCT in Rheumatoid Arthritis Patients

    Camille Figueiredo1, Mariana Perez 1, Ana Cristina de Medeiros Ribeiro 2, Valeria Caparbo 1 and Rosa Pereira 3, 1Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 2Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 3Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil

    Background/Purpose: Periarticular trabecular bone loss and local cortical bone erosions are typical features of bone disease in rheumatoid arthritis (RA) 1 . Little, however, is…
  • Abstract Number: 1314 • 2019 ACR/ARP Annual Meeting

    Patient-Specific Reference Values for Objective Physical Function Tests: Cross-Sectional Analysis Using Data from the Osteoarthritis Initiative

    Matthew Harkey1, Lori Lyn Price 2, Kieran Reid 3, Grace Lo 4, Shao-Hsien Liu 5, Kate Lapane 1, Lucas Dantas 6, Timothy McAlindon 7 and Jeffrey Driban 7, 1University of Massachusetts Medical School, Worcester, 2Tufts Medical Center, Tufts University, Boston, MA, 3Tufts University, Boston, 4Center of Excellence Michael E. DeBakey VAMC, Baylor College of Medicine, Houston, TX, 5University of Massachusetts Medical School, Worcester, MA, 6Tufts Medical Center, Boston, 7Tufts Medical Center, Boston, MA

    Background/Purpose: Despite an inter-play between objective physical function measures and various patient characteristics, no large-scale investigations in knee osteoarthritis (KOA) have explored complex interactions or…
  • Abstract Number: 1352 • 2019 ACR/ARP Annual Meeting

    Effects of Upadacitinib on Patient-Reported Outcomes After 24 Weeks in Patients with Active Rheumatoid Arthritis and an Inadequate Response to Conventional Synthetic or Biologic Disease-Modifying Anti-Rheumatic Drugs: Results from SELECT-NEXT and SELECT-BEYOND Phase 3 Studies

    Martin Bergman1, Namita Tundia 2, Heidi Camp 2, Sebastian Meerwein 3, Casey Schlacher 2, Debbie Goldschmidt 4, Yan Song 5 and Vibeke Strand 6, 1Drexel University College of Medicine, Stockholm, Sweden, 2AbbVie Inc., North Chicago, IL, 3AbbVie GmbH Co. KG, Ludwigshafen, Germany, Wiesbaden, Germany, 4Analysis Group, Inc., New York, NY, 5Analysis Group, Inc., Boston, MA, 6Division of Immunology/Rheumatology, Stanford University, Stanford, CA

    Background/Purpose: Treatment with upadacitinib (UPA), a selective Janus kinase-1 (JAK-1) inhibitor, resulted in significant and clinically meaningful improvements in patient-reported outcomes (PROs) at Week 12…
  • Abstract Number: 555 • 2018 ACR/ARHP Annual Meeting

    Three Year Outcomes of Patients with Elderly-Onset Rheumatoid Arthritis Treated with a Therapeutic Strategy Targeting Low Disease Activity, and Impact of Adverse Events on Physical Function

    Takahiko Sugihara1, Tatsuro Ishizaki2, Hiroyuki Baba3, Takumi Matsumoto3, Shoko Iga1, Takeshi Kusuda1, Marina Tsuchida1, Mari Kamiya3, Yoji Komiya3, Fumio Hirano4, Tadashi Hosoya3, Nobuyuki Miyasaka3 and Masayoshi Harigai5, 1Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 2Human Care Research Team, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan, 3Department of Medicine and Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan, 4Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Department of Rheumatology, Tokyo, Japan, 5Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan

    Background/Purpose: The aim of this study was to evaluate three year outcomes of patients with elderly-onset RA (EORA) who were treated with a therapeutic strategy…
  • Abstract Number: 1407 • 2018 ACR/ARHP Annual Meeting

    Differences in the Measurement Properties of the Patient-Reported Outcomes Measurement Information System Physical Function Short-Form 10a Among Racial/Ethnic Minorities with Rheumatoid Arthritis

    Zara Izadi1, Patricia Katz2, Gabriela Schmajuk3, Julie Gandrup4, Jing Li5, Milena Gianfrancesco6 and Jinoos Yazdany7, 1Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 2University of California San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA, 4Rheumatology, Odense University Hospital, Odense, Denmark, 5Medicine, UC San Francisco, San Francisco, CA, 6Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 7University of California, San Francisco, San Francisco, CA

    Background/Purpose: Most studies evaluating patient-reported outcomes such as the PROMIS Physical Function Short Form 10a (PF10a) in rheumatoid arthritis (RA) have been performed in white…
  • Abstract Number: 1676 • 2018 ACR/ARHP Annual Meeting

    Health Related Quality of Life over Time in a Multi-Ethnic Cohort of Patients with Systemic Lupus Erythematosus and Correlation with Disease Activity and Organ Damage

    Muhammad Mehmood Riaz1,2, Liang SHEN3, Lay Kheng Teoh4, Rangi Kandane-Rathnayake5 and Aisha Lateef6, 1Department of Medicine, National University Hospital, Singapore, Singapore, 2Department of Medicine, Aga Khan University, karachi, Pakistan, 3Biostatistics Unit, National University Health System, Singapore, Singapore, 4National University Hospital, Division of Rheumatology, University Medicine Cluster, Singapore, Singapore, 5School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 6Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

     Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic disease affecting the physical, social, and psychological well-being of patients. Health related quality of life (HRQoL) measures…
  • Abstract Number: 1953 • 2018 ACR/ARHP Annual Meeting

    Randomized Trial on Exercise at Late-Stage after Total Knee Replacement

    Sara R. Piva1, Michael Schneider1, Charity Moore-Patterson1, M. Beatriz Catelani1, Alexandra Gil1, Brian Klatt2, Anthony DiGioia3, Gustavo J. Almeida1, Samannaaz S. Khoja4, Gwendolin Sowa5 and James Irrgang1, 1Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 2Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 3University of Pittsburgh Medical Center, Pittsburgh, PA, 4Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 5Physical Medicine and Rehabilitation, University of Pittsburgh Medical Center, Pittsburgh, PA

    Background/Purpose: Total knee replacement (TKR) improves pain and quality of life; however, the functional limitations that existed for years before surgery tend to persist after…
  • Abstract Number: 2150 • 2018 ACR/ARHP Annual Meeting

    Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus

    Courtney Hoge1, C. Barrett Bowling2, S. Sam Lim3, Cristina Drenkard4 and Laura Plantinga5, 1Department of Epidemiology, Emory University, Atlanta, GA, 2Durham Veterans Affairs Medical Center, Durham, NC, 3Emory University School of Medicine, Atlanta, GA, 4Medicine/Rheumatology, Emory University, Atlanta, GA, 5Department of Medicine, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Lower socioeconomic status (SES) has been shown to be associated with poor physical functioning in systemic lupus erythematosus (SLE) patients; however, previous studies have…
  • Abstract Number: 2470 • 2018 ACR/ARHP Annual Meeting

    The Impact of Frailty on Changes in Physical Function Among Adults with Rheumatoid Arthritis

    James Andrews1, Laura Trupin2, Catherine Hough1, Edward H. Yelin3 and Patricia Katz2, 1Medicine, University of Washington, Seattle, WA, 2University of California San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA

    Background/Purpose: Frailty is a state of excess vulnerability to stressors and is associated with increased risk of poor health outcomes including physical disability. Frailty and…
  • Abstract Number: 625 • 2017 ACR/ARHP Annual Meeting

    Rapid Onset of Efficacy in Patients with Active Psoriatic Arthritis Treated with Ixekizumab: A Pooled Analysis of Data from Two Phase III Clinical Trials

    Atul A. Deodhar1, Kim A. Papp2, Catherine Shuler3, So Young Park3 and Tore K. Kvien4, 1Oregon Health & Science University, Portland, OR, 2K Papp Clinical Research and Probity Medical Research Inc, Waterloo, ON, Canada, 3Eli Lilly and Company, Indianapolis, IN, 4Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Rapid onset of clinical improvement is an important attribute of treatment success for patients with PsA. These analyses evaluate the speed of onset of…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology